Trials / Completed
CompletedNCT00044707
Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pramlintide acetate | Clear, colorless, sterile solution for SC injection. |
Timeline
- Start date
- 2002-08-01
- Primary completion
- 2002-09-01
- Completion
- 2002-09-01
- First posted
- 2002-09-05
- Last updated
- 2015-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00044707. Inclusion in this directory is not an endorsement.